AKBA
Akebia Therapeutics Inc.
$2.84
+$0.04(+1.61%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$750.36M
Volume
1.81M
52W Range
$1.24 - $4.08
Target Price
$7.40
Key Metrics Overview
| Market Cap | $750.36M | P/E Ratio | N/A |
| 52W High | $4.08 | 52W Low | $1.24 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 42.1% | 52W Position | 56.2% |
| Overall Score | 63 | Value Score | -- |
| Quality Score | -- | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $0 | EPS Next Est | $0.1 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $2.84 | +1.6% | 1.81M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW